R. Day

Optimizing adherence to allopurinol for gout: patients' perspectives
202324 citationsauthor #6
Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low‐flux filters, and the potential impact of dosing software
20231 citationsauthor #5
The safe use of metformin in heart failure patients both with and without T2DM: A cross‐sectional and longitudinal study
20233 citationsauthor #10
Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews
202380 citationsauthor #5
Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin
20231 citationsauthor #4
Short- and long-term effects of an electronic medication management system on paediatric prescribing errors
202220 citationsauthor #12
Who is asking? Requests for antimicrobial prescribing advice received by hospital pharmacists
20220 citationsauthor #5
Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection
202227 citationsauthor #3
Does splitting a tablet obtain an accurate dose? A systematic review and meta‐ analysis
20223 citationsauthor #5
Measuring quality of gout management in residential aged care facilities
20221 citationsauthor #3
LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring
202220 citationsauthor #2
Australian hospital outpatient pharmacies: service adaptations during the 2020 national coronavirus disease 2019 lockdown
20224 citationsauthor #6
Efficacy, safety, and dose‐dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta‐analysis
202224 citationsauthor #7
Persistence with urate‐lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions
202210 citationsauthor #2
OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan
20225 citationsauthor #3
Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
202216 citationsauthor #8
Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout
20224 citationsauthor #8
Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis.
20228 citationsauthor #6
Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients
20225 citationsauthor #5
Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients
20216 citationsauthor #4
Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation
202130 citationsauthor #5
Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions
202115 citationsauthor #8
The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews
202178 citationsauthor #5
Prescribing of SGLT2 inhibitors in primary care: a qualitative study of General Practitioners and Endocrinologists.
202121 citationsauthor #4
Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain
202174 citationsauthor #4
Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis
202124 citationsauthor #9
Co-designing a dashboard of predictive analytics and decision support to drive care quality and client outcomes in aged care: a mixed-method study protocol
202129 citationsauthor #7
Honorary Professor Garry Graham
20210 citationsauthor #1
Tacrolimus Therapy in Adult Heart Transplant Recipients: Evaluation of a Bayesian Forecasting Software
20214 citationsauthor #4
Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy
202110 citationsauthor #3
779-P: Prescribing of SGLT2 Inhibitors in Primary Care: A Qualitative Study of Primary Care Physicians and Endocrinologists
20210 citationsauthor #4
Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review.
202126 citationsauthor #4
Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum
20218 citationsauthor #2
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices
202124 citationsauthor #13
Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose‐recommendation software
202018 citationsauthor #7
Off‐label quetiapine prescribing in general hospital inpatients: an Australian experience
20200 citationsauthor #4
Healthcare expenditure and its predictors in a cohort of Australians living with sciatica
20201 citationsauthor #10
OASIS—a randomised, placebo-controlled trial of oral glucocorticoids for leg pain in patients with acute sciatica: trial protocol
20204 citationsauthor #7
A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study
202067 citationsauthor #6
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
202038 citationsauthor #3
Implementing large-system, value-based healthcare initiatives: a realist study protocol for seven natural experiments
202034 citationsauthor #9
Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review
202063 citationsauthor #4
Predictors of Success in Gout Treatment
20201 citationsauthor #1
Associations between double-checking and medication administration errors: a direct observational study of paediatric inpatients
202043 citationsauthor #7
A profile of health status and demographics of aged care facility residents with gout
20205 citationsauthor #3
Indications‐based prescribing: A challenge for hospital prescribers
20201 citationsauthor #4
Education to improve vancomycin use: the perspectives of educators and education recipients
202013 citationsauthor #7
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis
202020 citationsauthor #13
Researchers’ views on, and experiences with, the requirement to obtain informed consent in research involving human participants: a qualitative study
202075 citationsauthor #5
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure.
202025 citationsauthor #6
Emergency department care for low back pain: Should we adopt recommendations from primary care guidelines?
202012 citationsauthor #4
Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
20204 citationsauthor #6
Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package.
202018 citationsauthor #7
The safety and pharmacokinetics of metformin in patients with chronic liver disease
202016 citationsauthor #12
Better outcomes for patients with gout
202012 citationsauthor #1
Out‐of‐pocket spending among a cohort of Australians living with gout
20209 citationsauthor #6
Trends, determinants and differences in antibiotic use in 68 residential aged care homes in Australia, 2014–2017: a longitudinal analysis of electronic health record data
202018 citationsauthor #3
Should the cardio‐protective properties of sodium‐glucose cotransporter 2 inhibitors dictate therapeutic decision‐making in patients with type 2 diabetes
20201 citationsauthor #2
Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring
20207 citationsauthor #4
A pharmacokinetic‐pharmacodynamic study of a single dose of febuxostat in healthy subjects
20207 citationsauthor #8
A survey of Australian public attitudes towards funding of high cost cancer medicines.
20205 citationsauthor #6
"Some sort of fantasy land": A qualitative investigation of appropriate prescribing in cancer care.
20201 citationsauthor #6
Indications-based prescribing: A challenge for hospital prescribers
20200 citationsauthor #4
Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients.
202035 citationsauthor #9
Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing
20209 citationsauthor #6
Effects of Allopurinol on the Progression of Chronic Kidney Disease.
2020320 citationsauthor #9
Australian patient perspectives on the impact of gout
20209 citationsauthor #4
Analgesic medicines for adults with low back pain: protocol for a systematic review and network meta-analysis
202013 citationsauthor #12
Effect of dose administration aids on adherence to self-administered medications: a systematic review protocol
20194 citationsauthor #3
Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
201954 citationsauthor #7
Improving adherence to urate‐lowering therapy in people living with gout
20194 citationsauthor #9
Mandatory Medication Indications in Electronic Systems - The Prescriber Perspective
20195 citationsauthor #5
Role and impact of brain computed tomography in the management of drug overdoses and guideline recommendations
20196 citationsauthor #3
Do non-steroidal anti-inflammatory drugs cause osteoarthritis progression, a systematic review and meta analysis
20196 citationsauthor #8
Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?
20191 citationsauthor #1
Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
201910 citationsauthor #5
Embedding Electronic Medication Management Systems Into Practice: Identifying Barriers to Implementation Using a Theoretical Approach
20191 citationsauthor #6
Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection.
201913 citationsauthor #8
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis
201912 citationsauthor #13
Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance
20192 citationsauthor #6
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease
201914 citationsauthor #4
Do user preferences align with human factors assessment scores of drug–drug interaction alerts?
20199 citationsauthor #8
Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
2019110 citationsauthor #5
Management of gout in older people
201910 citationsauthor #1
Comparison of the Area-Under-The-Curve for Vancomycin Estimated Using Compartmental and Non-compartmental Methods in Adult Patients with Normal Renal Function.
201916 citationsauthor #5
Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
2019110 citationsauthor #6
Disease-Modifying Anti-rheumatic Drugs
20190 citationsauthor #4
Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection
20196 citationsauthor #5
Paracetamol versus placebo for knee and hip osteoarthritis.
2019127 citationsauthor #5
An experimental investigation of the impact of alert frequency and relevance on alert dwell time
20193 citationsauthor #9
A time and motion study of phlebotomists’ work
20180 citationsauthor #6
Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study
201817 citationsauthor #6
Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout
20188 citationsauthor #4
Reliability, ease of use and usefulness of I-MeDeSA for evaluating drug-drug interaction alerts in an Australian context
201814 citationsauthor #4
Use of colchicine in pregnancy: a systematic review and meta-analysis
201871 citationsauthor #4
Lactic Acidosis, Metformin Use, and Dose-Response Association.
20180 citationsauthor #3
Usability of Reports Generated by a Computerised Dose Prediction Software.
201810 citationsauthor #6
A Multicentre Open-Label Pharmacokinetic-Pharmacodynamic Study of Febuxostat in Patients with Chronic Gout
20180 citationsauthor #1
Barriers and facilitators of appropriate vancomycin use: prescribing context is key
201820 citationsauthor #6
Prescribing Skills Assessment – initial results from an Australian cross-institutional pilot
20181 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT